As I recall, GVHD was supposed to be a very small and short study. I assume it could not have taken very long to sign up 10 patients, and therefore expect results to be announced soon.
Hopefully, these results will be favorable, and will get a better market reaction than the disappointing reaction to the very good combo study results announced today.
Market Data 
Markets 
AI
